The Hair Growth Cycle and Medication Interference Hair follicles undergo three distinct phases: anagen (growth), catagen (transition), and telogen (resting)
Using two injected compounds means more injection sites and more chances for redness or irritation
Correct subcutaneous injection technique is essential for safe and effective tirzepatide administration
Outside of a clinical trial, access to an unlicensed investigational medicine such as retatrutide would only be possible under specific MHRA frameworks for example, the Early Access to Medicines Scheme (EAMS) , which requires a positive scientific opinion from the MHRA before use outside trials can be considered
Treatment includes consultation, a tailored plan, weekly injection guidance, and ongoing monitoring
Peptides such as BPC-157 (Body Protection Compound), Ipamorelin, Kisspeptin, and Sarcotropin are what have been targeted